What category is paracetamol diclofenac sodium and caffeine tablets?

In the pharmaceutical industry, the combination of Paracetamol, Diclofenac Sodium, and Caffeine is categorized as a Fixed-Dose Combination (FDC) Analgesic and Antipyretic. Specifically, it belongs to the therapeutic class of Multimodal Pain Management agents.

As a pharmacist and manufacturer, I view this as a “Triple-Action” formulation. It combines a non-NSAID analgesic (Paracetamol), a potent NSAID (Diclofenac), and an alkaloid adjuvant (Caffeine) to attack pain through three distinct biological pathways.

Therapeutic Category Breakdown

  • Paracetamol: Non-Opioid Analgesic & Antipyretic.

  • Diclofenac Sodium: Non-Steroidal Anti-Inflammatory Drug (NSAID).

  • Caffeine: Central Nervous System (CNS) Stimulant & Analgesic Adjuvant.

Mechanism: The Triple-Action Synergy

This combination is technically superior for acute pain because it addresses both the chemical signals of pain and the physical inflammation.

Anti-Inflammatory (Diclofenac): It inhibits the COX-1 and COX-2 enzymes, stopping the production of prostaglandins at the site of injury, thereby reducing swelling and “peripheral” pain.

Central Analgesia (Paracetamol): It works primarily in the Central Nervous System, elevating the overall pain threshold and reducing fever.

The Accelerator (Caffeine): It blocks Adenosine receptors and increases the absorption rate of the other two ingredients, allowing for a faster “onset of action” and deeper pain relief.

The Pharmacist’s “Technical Warning”

As you promote your firm on digital platforms, providing these technical nuances is essential for clinical authority:

  • Gastric Protection: Due to the Diclofenac content, these tablets must be taken with food to protect the stomach lining from irritation or potential ulceration.

  • The “Double-Dosing” Risk: Advise patients not to take additional Paracetamol or NSAIDs (like Ibuprofen) while using this FDC, as it increases the risk of liver toxicity and renal strain.

  • Cardiac/Renal Alert: This category should be used with caution in patients with high blood pressure or kidney impairment due to the sodium-retaining properties of Diclofenac.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Acute Pain” USP: On your marketplace, highlight this as a “Fast-Acting” solution for severe dental pain, post-surgical recovery, and acute musculoskeletal injuries.

  • Stability for Export: Utilizing Alu-Alu blister packaging is essential for this combination, as Paracetamol and Caffeine can be sensitive to moisture. This ensures a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international health tenders where multidimensional pain relief is a priority.

What is diclofenac sodium 25 mg used for?

In the pharmaceutical industry, Diclofenac Sodium 25 mg is a potent non-steroidal anti-inflammatory drug (NSAID) of the phenylacetic acid derivative class. As a pharmacist, I view the 25 mg strength as a versatile “titration dose,” often used for acute pain management or as a starting dose to minimize gastrointestinal (GI) side effects.

Primary Clinical Uses

  • Acute Pain Management: Effective for the short-term relief of mild to moderate pain, such as toothaches, primary dysmenorrhea (period pain), and post-operative pain.

  • Inflammatory Conditions: Used to treat symptoms of Rheumatoid Arthritis (RA), Osteoarthritis (OA), and Ankylosing Spondylitis.

  • Musculoskeletal Disorders: Relieves pain and inflammation associated with sprains, strains, backache, and tendonitis.

  • Migraine Attacks: In specific fast-acting formulations (like potassium salts or specific sodium dispersibles), it is used to treat acute migraine episodes.

    Mechanism of Action

Diclofenac Sodium works by inhibiting the enzyme Cyclooxygenase (COX). Specifically, it inhibits both COX-1 and COX-2, though it shows a slight preference for COX-2.

By blocking these enzymes, Diclofenac prevents the synthesis of prostaglandins—the chemical messengers responsible for signaling pain, inducing fever, and causing inflammation. Unlike the potassium salt version (which is faster-acting), the sodium salt is typically formulated for a slightly more sustained release to provide longer-lasting relief.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diclofenac Sodium is a high-volume “essential” product:

  • Enteric Coating (Critical): Diclofenac is notorious for causing gastric irritation. As a WHO-GMP manufacturer, we almost always apply a high-quality enteric coating to these tablets. This ensures the drug bypasses the acidic environment of the stomach and dissolves in the small intestine, significantly improving patient tolerance.

  • Stability & Shelf Life: Diclofenac is stable, but sensitive to moisture. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is a key selling point for export to Zone IVb regions like Africa, Southeast Asia, and the Middle East.

  • Regulatory Documentation: We provide full CTD/eCTD Dossiers and comparative dissolution studies against the innovator (Voltaren) to support our B2B partners in rapid international registration.

  • Market Positioning: The 25 mg dose is frequently used in pediatric or geriatric populations where lower dosing is required to manage the safety profile.

Add to cart